Respiratory Medicine
Volume 104, Issue 9 , Pages 1319-1325 , September 2010

Sniff nasal inspiratory pressure versus IC/TLC ratio as predictors of mortality in COPD

  • Alastair J. Moore

      Affiliations

    • Respiratory Muscle Laboratory, Royal Brompton Hospital and National Heart Lung Institute, Fulham Road, London SW3 6NP, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 07976 924582; fax: +44 207 351 8939.
    • ,
  • Rosa Suades Soler

      Affiliations

    • Respiratory Muscle Laboratory, Royal Brompton Hospital and National Heart Lung Institute, Fulham Road, London SW3 6NP, UK
    • Experimental Sciences and Health Department, Universitat Pompeu Fabra, Barcelona 88 08003, Spain
    • ,
  • Edward J. Cetti

      Affiliations

    • Respiratory Muscle Laboratory, Royal Brompton Hospital and National Heart Lung Institute, Fulham Road, London SW3 6NP, UK
    • ,
  • S. Amanda Sathyapala

      Affiliations

    • Respiratory Muscle Laboratory, Royal Brompton Hospital and National Heart Lung Institute, Fulham Road, London SW3 6NP, UK
    • ,
  • Nicholas S. Hopkinson

      Affiliations

    • Respiratory Muscle Laboratory, Royal Brompton Hospital and National Heart Lung Institute, Fulham Road, London SW3 6NP, UK
    • ,
  • Michael Roughton

      Affiliations

    • Respiratory Muscle Laboratory, Royal Brompton Hospital and National Heart Lung Institute, Fulham Road, London SW3 6NP, UK
    • ,
  • John Moxham

      Affiliations

    • Respiratory Muscle Laboratory, King's College London School of Medicine, London SE5 9RS, UK
    • ,
  • Michael I. Polkey

      Affiliations

    • Respiratory Muscle Laboratory, Royal Brompton Hospital and National Heart Lung Institute, Fulham Road, London SW3 6NP, UK

Received 16 October 2009 ,Accepted 1 March 2010.

References 

  1. Martinez FJ, Foster G, Curtis JL, et al. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med. 2006;173:1326–1334
  2. Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli BR. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J. 2004;23:28–33
  3. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med. 2003;167:544–549
  4. Tojo N, Ichioka M, Chida M, Miyazato I, Yoshizawa Y, Miyasaka N. Pulmonary exercise testing predicts prognosis in patients with chronic obstructive pulmonary disease. Intern Med. 2005;44:20–25
  5. Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:1791–1797
  6. Lando Y, Boiselle PM, Shade D, et al. Effect of lung volume reduction surgery on diaphragm length in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159:796–805
  7. Swallow EB, Reyes D, Hopkinson NS, et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax. 2007;62:115–120
  8. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005–1012
  9. Casanova C, Cote C, de Torres JP, et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171:591–597
  10. Polkey M, Kyroussis D, Hamnegard C, Mills G, Green M, Moxham J. Diaphragm strength in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996;154:1310–1317
  11. Hatipoglu U, Laghi F, Tobin MJ. Does inhaled albuterol improve diaphragmatic contractility in patients with chronic obstructive pulmonary disease?. Am J Respir Crit Care Med. 1999;160:1916–1921
  12. Hamnegard CH, Polkey MI, Thylen A, Nilsson F, Schersten H, Bake B. Effect of lung volume reduction surgery for emphysema on diaphragm function. Respir Physiol Neurobiol. 2006;150:182–190
  13. Hopkinson NS, Toma TP, Hansell DM. Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema. Am J Respir Crit Care Med. 2005;171:453–460
  14. ATS/ERS statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002;166:518–624
  15. De Troyer A. Effect of hyperinflation on the diaphragm. Eur Respir J. 1997;10:708–713
  16. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163:1256–1276
  17. Fabbri LM, Hurd SS. Global strategy for the diagnosis, management and prevention of COPD: 2003 update. Eur Respir J. 2003;22:1–2
  18. Hopkinson NS, Man WD, Dayer MJ, et al. Acute effect of oral steroids on muscle function in chronic obstructive pulmonary disease. Eur Respir J. 2004;24:137–142
  19. Hopkinson NS, Eleftheriou KI, Payne J, et al. +9/+9 Homozygosity of the bradykinin receptor gene polymorphism is associated with reduced fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr. 2006;83:912–917
  20. Blakemore WS, Forster RE, Morton JW, Ogilvie CM. A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide. J Clin Invest. 1957;36:1–17
  21. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993;16:5–40
  22. Miller JM, Moxham J, Green M. The maximal sniff in the assessment of diaphragm function in man. Clin Sci (Lond). 1985;69:91–96
  23. Uldry C, Janssens JP, de Muralt B, Fitting JW. Sniff nasal inspiratory pressure in patients with chronic obstructive pulmonary disease. Eur Respir J. 1997;10:1292–1296
  24. Creutzberg EC, Schols AM, Weling-Scheepers CA, Buurman WA, Wouters EF. Characterization of nonresponse to high caloric oral nutritional therapy in depleted patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161:745–752
  25. Murciano D, Rigaud D, Pingleton S, Armengaud MH, Melchior JC, Aubier M. Diaphragmatic function in severely malnourished patients with anorexia nervosa. Effects of renutrition. Am J Respir Crit Care Med. 1994;150:1569–1574
  26. Thurlbeck WM. Diaphragm and body weight in emphysema. Thorax. 1978;33:483–487
  27. Clayton N. Lung Function Service Provision. In: ARTP Working Groups on Standards of Care and Recommendations for Lung Function Departments, 2007.
  28. Bates DV, Knott JM, Christie RV. Respiratory function in emphysema in relation to prognosis. Q J Med. 1956;25:137–157
  29. Dubois P, Machiels J, Smeets F, Delwiche JP, Lulling J. CO transfer capacity as a determining factor of survival for severe hypoxaemic COPD patients under long-term oxygen therapy. Eur Respir J. 1990;3:1042–1047
  30. Fishman A, Martinez F, Naunheim K, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003;348:2059–2073

PII: S0954-6111(10)00099-5

doi: 10.1016/j.rmed.2010.03.001

Respiratory Medicine
Volume 104, Issue 9 , Pages 1319-1325 , September 2010

Article Tools

* Image Usage & Resolution